Archive: April 2017
Hepatitis C
Hepatitis C Virus and Liver Transplantation
Kalyan Ram Bhamidimarri, MD, MPH, Sanjaya K. Satapathy, MBBS, MD, and Paul Martin, MD
Abstract: Hepatitis C virus (HCV) is a major cause of death from infectious disease and is still the leading indication for liver transplantation in the […]
IBD
Fecal Microbiota Transplantation: From Clostridium difficile to Inflammatory Bowel Disease
Robert J. Gianotti, MD, and Alan C. Moss, MD
Abstract: Fecal microbiota transplantation (FMT) has evolved from a case report in the medical literature to the basis of major innovations in the treatment of […]
Clostridium difficile
Evidence-Based Approach to Clostridium difficile Infection
Stuart Johnson, MD
G&H How common is Clostridium difficile infection in the United States? SJ In 2009, the Centers for Disease Control and Prevention (CDC) started active surveillance […]
Endoscopy
Current Management of Low-Grade Dysplasia in Barrett Esophagus
Gary W. Falk, MD, MS
Abstract: Low-grade dysplasia in Barrett esophagus remains an ongoing challenge in clinical management. Recent studies suggest an increased risk in progression of low-grade dysplasia to […]
Endoscopy
Endoscopic Management of Zenker Diverticula
Todd H. Baron, MD
G&H When should a Zenker diverticulum be treated? TB Diagnosis and treatment of Zenker diverticula are symptom-driven, as they are uncommonly found incidentally. Treatment, therefore, […]
IBD
Common Chronic Complications Following Inflammatory Bowel Disease Surgery
Scott A. Strong, MD
G&H What are the most common surgeries performed for the treatment of inflammatory bowel disease? SS The most common operations for Crohn’s disease are resection, […]
HCC
The BALAD-2 and GALAD Biomarker Models for Hepatocellular Carcinoma
Philip J. Johnson, MD
G&H Do biomarkers currently have a role in hepatocellular carcinoma? PJ The role of biomarkers in hepatocellular carcinoma (HCC) is controversial. For example, the best-known […]
Hepatology
Supplement-Induced Liver Injury
Victor J. Navarro, MD
G&H How common is supplement-induced liver injury in the United States? VN That is a difficult question to answer because the true number of people […]
Gastro-Hep News
Gastro-Hep News
Samantha Alleman
Committee for Medicinal Products for Human Use Votes for 8-Week Treatment Option for Hepatitis C Virus Infection On February 28, 2017, the Committee for Medicinal Products […]
Letter From the Editor
Letter From the Editor: Fecal Microbiota Transplantation: An Update
Gary R. Lichtenstein, MD, AGAF, FACP, FACG
Once considered a medical curiosity, fecal microbiota transplantation is starting to become a fairly widespread practice for the treatment of Clostridium difficile infection. Can this procedure, […]